News

For The Boston Beer Company, Inc. (NYSE: SAM) shareholders, the last two years have been far from a Boston Tea Party. Maybe it relates to the Bruins, Celtics, Patriots and Red Sox teams’

Shares of Old Dominion Freight Line inc. (NASDAQ: ODFL) just keep on truckin’ higher. As of June 28, stock of the less-than-truckload (LTL) specialist is up 13.49% for the week,  

A catalyst for

Shares of Old Dominion Freight Line inc. (NASDAQ: ODFL) just keep on truckin’ higher. As of June 28, stock of the less-than-truckload (LTL) specialist is up 13.49% for the week,  

A catalyst for

Shares of Old Dominion Freight Line inc. (NASDAQ: ODFL) just keep on truckin’ higher. As of June 28, stock of the less-than-truckload (LTL) specialist is up 13.49% for the week,  

A catalyst for

Shares of AeroVironment Inc. (NASDAQ: AVAV) rose by as much as 5.9% in the after-market hours of Tuesday evening. The price action stems from the company releasing its fourth quarter 2023 earnings

General Mills (NYSE: GIS) retreated following the Q4 results and guidance marking an opportune time to buy the stock. The retreat is due to mixed results and guidance that left investors wanting

As shareholders of pet insurer Trupanion Inc. (NASDAQ: TRUP) learned last month, when you post a net loss that's twice what Wall Street expected, things get a little fuzzy.

The May 5

Clinical stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive phase two clinical trial results. The company specializes in nanobodies, fragments of antibodies

Delta Airlines (NYSE: DAL) share price struggled to gain traction until just a few weeks ago, but it is gaining momentum now. The fear of economic headwinds offset the underlying strength in

Korn Ferry (NYSE: KFY) reported its fourth quarter and full-year 2023 earnings on June 27. KFY stock is down over 4% in early trading on weak guidance for the coming quarter. But that's likely to

Is it time to back up the truck and start loading up on equities? 

Analysts seem to think so, according to a June 23 report from researcher FactSet.

That’s despite more companies issuing

Vuzix Corporation (NASDAQ: VUZI) makes augmented reality (AR) glasses and solutions for the manufacturing, healthcare, aerospace, military and industrial industries. Most consumers might equate AR

In an ever-evolving world of investments, and increased uncertainty in global markets, owning or investing in high dividend yield stocks has emerged as an enticing avenue for investors seeking a

ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles that target and selectively deliver

The artificial intelligence (AI) deployment trend is bolstering stock prices throughout the market. Many stocks are just rising with the currents, but many companies are seeing a material impact

FactSet Research System (NYSE: FDS) stock is down more than 6% following the Q3 earnings release on a knee-jerk reaction to the news. The company issued a tepid report and guidance but not the

Patterson Companies, Inc. (NASDAQ: PDCO) is a dual-story that includes healthcare for humans and animals. The company operates in 2 segments, Dental and Animal Health, and both are growing. The

Like many quick service restaurant (QSR) operators, pizza places have struggled in recent months. Cash-strapped consumers are spending less on pricier takeout food and delivery. Higher wage and

Like other mature drug manufacturers, Eli Lilly and Company (NYSE: LLY) is banking on innovative biotechnology platforms to drive its next growth phase. 

On Tuesday, the nearly 150-year

When it comes to gaining an edge in the market, few tactics are as controversial and captivating as buying or selling securities based on privileged information. However, the Securities and

When it comes to gaining an edge in the market, few tactics are as controversial and captivating as buying or selling securities based on privileged information. However, the Securities and

When it comes to gaining an edge in the market, few tactics are as controversial and captivating as buying or selling securities based on privileged information. However, the Securities and